Clinical Trials Browser

repotrectinib × Tumor-Agnostic × 90 days × Clear all

NCT05004116 2026-06-04

A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Phase 1/2 Recruiting

Neoplasm Metastasis